Cardiac Reverse Remodeling After Transcatheter Patent Ductus Arteriosus Closure in Adults

Zahra Khajali1, Ata Firouzi2, Farshad Shakerian2

  • 1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Insights

Percutaneous closure of patent ductus arteriosus (PDA) in adults shows promising cardiac improvements. This study evaluated long-term outcomes, comparing adult results to pediatric data for transcatheter closure (TCC) of PDA.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pediatric Cardiology

Background:

  • Patent ductus arteriosus (PDA) is commonly treated in childhood with excellent outcomes.
  • Long-term results of percutaneous PDA closure in adults remain less understood.
  • Positive cardiac reverse remodeling is well-documented in pediatric PDA patients.

Purpose of the Study:

  • To evaluate the long-term outcomes (at least 1-year follow-up) of transcatheter closure (TCC) for patent ductus arteriosus (PDA) in adult patients.
  • To compare hemodynamic and cardiac reverse remodeling findings in adults post-TCC with existing pediatric and adult data.
  • To assess the comprehensibility of percutaneous PDA closure outcomes in the adult population.

Main Methods:

  • Retrospective cohort study design.
  • Inclusion of 121 adult patients (age >16 years) undergoing TCC for PDA between 2012 and 2018.
  • Minimum 1-year follow-up for all included patients.

Main Results:

  • (Results not detailed in the abstract, but would typically include hemodynamic changes and degree of cardiac reverse remodeling.)
  • Comparison of adult TCC outcomes against established pediatric benchmarks.
  • Assessment of the clinical significance of TCC in adult PDA management.

Conclusions:

  • Transcatheter closure of PDA in adults warrants further investigation for long-term efficacy.
  • Understanding adult outcomes is crucial for comprehensive PDA management guidelines.
  • Potential for positive cardiac remodeling in adults following PDA closure, comparable to pediatric populations.